Cardiology Online

Home

Welcome

Scientific Committees

International Academy of Cardiology Awards

Acknowledgements

Timetable

Participant Letter

Program Topics

Scientific Program

General Information

Social Program

List of Exhibitors

Abstract Guidelines

Abstract Form

Instructions for the Preparation of Posters

Writing Instructions & Sending Your Article(s) to the Proceedings Book

Registration Form

Accommodation

Accommodation Form

Exhibition

Social Program

Contact Us

* To download Scientific Program

* To download Brochure

 

 

MOLECULAR AND CELLULAR BIOLOGY

Unraveling the Myocardial Interstitium in Heart Failure: Mechanisms and Prospects for Therapy
Francis G. Spinale
, Medical University of South Carolina, Charleston, SC, U.S.A.

Molecular Control of Cardiac Metabolic Switches: Role of PPAR and Other Nuclear Receptors
Daniel P. Kelly, St. Louis, MO, U.S.A.
Cellular, Ionic, Molecular and Genetic Aspects of the Brugada Syndrome
Charles Antzelevitch, Masonic Medical Research Laboratory, Utica, NY, U.S.A.
The Cause of Dystrophin Disruption, Translocation and Fragmentation in the Progression of Heart Failure
Teruhiko Toyo-oka
, University of Tokyo, P/Graduate School of Med., Tokyo, Japan
Protein Kinase and the Progression of Cardiac Disease
Peter M. Buttrick, University of Illinois, Chicago, IL, U.S.A.
Modulation of MMP Expression by Cytokines and Beta Blocker
Matthias Pauschinger, University Hospital Benjamin Franklin, Berlin, Germany
Sarcoplasmic Reticulum Function in Heart Failure Due to Volume Overload
Thomas Netticadan, St. Boniface Hospital Research Centre, Winnipeg, Manitoba, Canada
Matrix Metalloproteinases in Heart Failure: Potential for Treatment?
Anique Ducharme, Institut de Cardiologie de Montreal, Montreal, Quebec, Canada
VASCULAR BIOLOGY, ENDOTHELIAL FUNCTION

Chronic Inhibition of Nitric Oxide Synthase Induces Hypertension and Cardiomyocyte Mitochondrial Collagen Remodeling in the Absence of Hypertrophy
Marcos A. Rossi
, University of Sao Paulo, Ribeirao Preto, S.P., Brazil

Endothelial Protection by Nitric Oxide and Aspirin: Role of Heme Oxygenase-1 and Ferritin
Henning Schroeder
, Martin Luther University School of Pharmacy, Halle (Saale), Germany
GENETIC STUDIES
Preventing Progressive Left Ventricular Dilation Is Integral to Normalization of Gene Expression in Heart Failure
Hani N. Sabbah, Henry Ford Heart & Vascular Institute, Detroit, MI, U.S.A.
Genetic Mechanisms of Heart Failure
Jeffrey A. Towbin, Texas Children's Hospital/Baylor College of Med, Houston, TX, U.S.A.
Chip-ping Away at Heart Failure
Choong-Chin Liew, Brigham and Women's Hospital, Boston, MA, U.S.A.
Genetic Alteration in Natriuretic Peptide Receptor -A Causes Hypertension and Congestive Heart Failure
Kailash Pandey, Tulane University School of Medicine, New Orleans, LA, U.S.A.
Synergistic Polymorphisms of b1- and a2c-Adrenergic Receptors and the Risk of Congestive Heart Failure
Lynne E. Wagoner, University of Cincinnati, Cincinnati, OH, U.S.A.
Differential Gene Expression in the Failing and Rescued Heart
Burns C. Blaxall, Duke University Medical Center, Durham, NC, U.S.A.
CELL TRANSPLANTATION
Autology Bone Marrow: Results of Clinical Study
Ron Waksman, Washington Cardiology Center, Washington, DC, U.S.A.
Cell Transplantation for Cardiovascular Repair: A Moving Target
Doris Taylor, Duke University Medical Center, Durham, NC, U.S.A.
Myoblast Cell Transplantation for the Treatment of Congestive Heart Failure
Nabil Dib, Arizona Heart Institute and Hospital, Phoenix, AZ, U.S.A.
Stem Cell Therapy for Myocardial Regeneration: Do We Need Direct Intramyocardial Injection?
Raj R. Makkar, Cedars-Sinai Medical Center, Los Angeles, CA, U.S.A.
Real-time MRI for the delivery and surveillance of mesenchymal stem cells after recent acute myocardial infarction in swine.
Robert J. Lederman, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD
ANGIOGENESIS
Angiogenesis Clinical Trials
Timothy A. Sanborn, Evanston Northwestern Healthcare, Evanston, IL, U.S.A.
Options for No-Option Patients: Complex Interventions, Angiogenesis/Myogenesis
Roger Laham, BIDMC / Harvard Medical School, Boston, MA, U.S.A.
Evolving Treatment Strategies for Unrevascularizable Ischemic Coronary Disease
Greg Barsness, Mayo Clinic, Rochester, MN, U.S.A.
ECHOCARDIOGRAPHY
Newer Aspects of Echocardiography
Navin C. Nanda, University of Alabama at Birmingham, Birmingham, AL, U.S.A.
Echocardiography in 2003: New Questions, New Challenges, New Answers
Fausto J. Pinto, University Hospital Sta Maria, Lisbon Universit, Lisboa Codex, Portugal
Role of Miniaturized Echocardiographic Platforms in Clinical Practice
Kirk T. Spencer, University of Chicago Medical Center, Chicago, IL, U.S.A.
New Trends in Postoperative Diagnosis and Treatment Utilizing Substernal Epicardial Echocardiography
Anthony P. Furnary, Oregon Health Sciences University Hospital, Portland, OR, U.S.A. 
Feasibility of Simultaneous Echocardiographic Imaging of Myocardial Perfusion and Regional Left Ventricular Function Using Color-Encoded Contrast Enhanced Power Modulation
Jeanne M. DeCara, University of Chicago Medical Center, Chicago, IL, U.S.A.
NEW DEVELOPMENTS IN CARDIAC IMAGING
Complementary Roles of Cardiac CT and Nuclear Cardiology in Assessment of the Cardiac Patient
Daniel S. Berman, Cedars Sinai Medical Center, Los Angeles, CA, U.S.A.
Diagnostic Role of MRI in Congestive Heart Failure
Vinzenz Hombach, Vice-President of the University of Ulm, Ulm, Germany
Noninvasive Detection of Coronary Vasomotor Dysfunction: An Index of Preclinical Atherosclerosis
Heinrich R. Schelbert, University of California, Los Angeles, Los Angeles, CA, U.S.A.
Analysis of the Christmas Trial: Is the Search For Hibernating Myocardium Important?
Avijit Lahiri, Northwick Park Hospital & Instit. for Med. Res., Middlesex, England
Clinical Applications of Coronary CT
Michael Motro, Sheba Medical Center, Tel Hashomer, Israel
Imaging in the Management of the Patient with Heart Failure
Francesco Fedele, Universita' Degli Studi Di Roma "la Sapienza", Roma, Italy 
Application of Angioscopy for Diagnosis of Atherosclerosis
Takanobu Tomaru, Toho University Sakura Hospital, Japan
The Wavefront of Myocardial Contraction Revisited
Manel Ballester, Universitat de Lleida, Lieida, Spain
Monitoring the Effectiveness of Medical Therapy for Ischemic Heart Disease with ECG-Gated SPECT Myocardial Perfusion Imaging
Ronald G. Schwartz, University of Rochester Medical Center, Rochester, NY, U.S.A.
Assessment of Myocardial Viability by Cardiac Magnetic Resonance
Luis J. Jimenez-Borreguero, Hospital Universitario Principe Asturias, Madrid, Spain 
ATHEROSCLEROSIS: PATHOGENESIS AND TREATMENT
Vaccination for Atherosclerosis Prevention: Promises and Problems
Prediman K. Shah, Cedars-Sinai Medical Center, Los Angeles, CA, U.S.A.
Pathogen Burden, the Prime Culprit of Atherosclerosis
Junbo Ge, Shanghai Medical University / Zhongshan Hospital, Shanghai, P.R. China
The Vulnerable Plaque: New Insights into Old Morphology
Christian C. Haudenschild, American Red Cross, Rockville, MD, U.S.A. 
How Macrophages Get Fat
Howard S. Kruth, NHLBI, NIH, Bethesda, MD, U.S.A. 
Antioxidants and Atherosclerosis
Jean-Claude Tardif, Montreal Heart Institute, Montreal, Quebec, Canada
Atherosclerosis Regression - A Myth or Reality?
Adarsh Kumar, Govt. Medical College/G.N.D. Hospital, Amritsar, India
EPIDEMIOLOGY OF ISCHEMIC HEART DISEASE
Socio-Economic Status and Its Clinical Implication on Coronary Artery Disease
Christos Pitsavos, University of Athens, Chalandri Athens, Greece
Climatological Variations and Coronary Heart Disease Mortality
Demosthenes B. Panagiotakos, University of Athens, Glyfada, Attica, Greece
ACUTE CORONARY SYNDROMES, ACUTE MYOCARDIAL INFARCTION
Silent Infarction and Ischemia: Revisited in 2003
Shlomo Stern, Bikur Cholim Hospital, Jerusalem, Israel
Use of 80-Lead Body Map Electrocardiography to Diagnose Acute ST Elevation Myocardial Infarction
Joseph P. Ornato, Virginia Commonwealth Health System, Richmond, VA, U.S.A.
Role of P-Selectin Antagonists in Acute Myocardial Infarction
Jean-Francois Tanguay, Montreal Heart Institute, Montreal, Quebec, Canada
Acute Coronary Syndromes: Diagnostic Challenges and Therapeutic Options
Osama Abdel-Aziz, Cairo, Egypt
ANTITHROMBOTIC AND ANTIPLATELET THERAPY
Antithrombotic Therapy for Patients with Heart Failure: Blocking Platelets and Fibrin Formation
James H. Chesebro, Mayo Clinic Jacksonville, Jacksonville, FL, U.S.A.
Reperfusion Injury Can Not Be Prevented Because It Does Not Exist
William Ganz, Cedars-Sinai Medical Center, Los Angeles, CA, U.S.A.
Modern Developments in Thrombolytic Therapy in Acute Myocardial Infarction
Hans Martin Hoffmeister, Chefarzt Prof. Dr. H.M. Hoffmeister, Solingen, Germany
Development of Novel Antithrombotics Agents
Paul R. Eisenberg, Eli Lilly and Company, Indianapolis, IN, U.S.A.
Approach to Patients of Acute Non-ST Elevation Myocardial Infarction with Early Conservative Management
Shih-Chung Lin, Vice President, Kuo General Hospital, Tainan, Taiwan
Anticoagulation During Pregnancy
Tasneem Naqvi, Cedars-Sinai Medical Center, Los Angeles, CA, U.S.A.
INTERVENTIONAL CARDIOLOGY
Clinical Impact of Periprocedural Microembolizations During PCI
Michael Haude, University of Essen, Essen, Germany
Catheter Closure of Ventricular Septal Defects
Horst Sievert, Cardiovascular Center Bethaniem CCB, Frankfurt, Germany
Application of Excimer Laser Angioplasty in Acute Coronary Syndromes
On Topaz, McGuire VA Medical Ctr, Division of Cardiology, Richmond, VA, U.S.A.
Use of Intracardiac Echocardiography for Closure of ASDs and PFOs
Saibal Kar, Cedars-Sinai Medical Center, Los Angeles, CA, U.S.A.
Left Ventricular Function After Angioplasty (PTCA or Stenting) of Infarct Related Artery: Early and Midterm Results
David G. Iosseliani, Moscow, Russia
STENTS: NEW DEVICES / OPTIMAL APPLICATION
Stents, Design and Vessel Wall Biology: Two Decades of Progress
Rafael Beyar, Rambam Medical Center, Haifa, Israel
Drug Eluting Stents: Special Considerations in the Application of Restenosis
George W. Vetrovec, Virginia Commonwealth University, Richmond, VA, U.S.A.
Results with Drug Eluting Stents in the Real World
Volker Klauss, Klinikum der Universitat Munchen, Munchen, Germany
Current Status of Drug Eluting Stents - Did Expectation Translate Into Reality?
A. H. Gershlick, University of Leicester, Leicester, England, United Kingdom
Nanotechnology - Novel Technology Using Ultrapure Metals to Improve Endovascular Stents
Steven R. Bailey, University of Texas Health Sciences Center, San Antonio, TX, U.S.A.
Drug Eluting Stents: One Year Later, Where Are We Now?
Maurice Buchbinder, Sharp Health Care, San Diego, CA, U.S.A.
Is Carotid Angioplasty and Stenting Under Protection Becoming the Gold Standard Treatment of Carotid Artery Stenosis?
Michel Henry, Nancy, France
DRUG THERAPY IN ISCHEMIC HEART DISEASE
Beta Blockade as Cardioprotection in Coronary Patients in the Era of Thrombolysis, Percutaneous Coronary Intervention, and ACE Inhibition
Barry F. Uretsky, University of Texas Medical Branch at Galveston, Galveston, TX, U.S.A.
Management of Stable Angina: Drugs, Devices, Stents or Coronary Bypass Surgery
Udho Thadani, University of Oklahoma HSC, Oklahoma City, OK, U.S.A.
Reducing CV Events - Focus on New Pharmacologic Trials
Robert DiBianco, Washington Adventist Hospital, Takoma Park, MD, U.S.A.
MODIFICATION OF LIPOPROTEINS AND CORONARY DISEASE
New Understanding of Atherosclerosis: Is the Lipid Theory Debunked?
Carlos M. Ferrario, Wake Forest University School of Medicine, Winston-Salem, NC, U.S.A.
Statins and Stroke: The Mode of Action in Stroke Prevention and Therapy
Rodolfo Paoletti, University of Milan, Milan, Italy
Polyunsaturated Fats in the Management of the Diseased Artery
W. Virgil Brown, Atlanta VA Medical Center (111), Decatur, GA, U.S.A.
Atherosclerosis Regression by Lipid Lowering
Clive Rosendorff, VA Medical Center, Bronx, NY, U.S.A.
Effects of Statins on Vascular Function and Myocardial Ischemia
Prakash C. Deedwania, University of California, San Francisco Program, Fresno, CA, U.S.A. 
Pleiotropic Actions of Statin Agents Including Applicability to CHF
Scott Wright, Mayo Clinic, Rochester, MN, U.S.A.
HYPERTENSION
Treating Hypertension in Patients Who Present Coronary Artery Disease, Heart Failure and/or Cardiac Arrhythmias
Ariel J. Reyes, Institute of Cardiovascular Theory, Montevideo, Uruguay
Angiotensin and the Left Ventricle
Philip R. Liebson, Rush Presbyterian-St. Luke's Medical Center, Chicago, IL, U.S.A.
Management of Exercise Related Hypertension
Yzhar Charuzi, Los Angeles, CA, U.S.A. 
New and Evolving Strategies in the High Risk Hypertensive Patient
Gabriel B. Habib, Houston VA Medical Center, Houston, TX, U.S.A.
DIABETES AND HEART DISEASE
Diabetes and Coronary Valvular Disease
Jonathan Abrams, University of New Mexico HSC, Albuquerque, NM, U.S.A.
PRIMARY PREVENTION OR CORONARY ARTERY DISEASE
Guidelines for the Preventrion of Coronary Heart Disease: What Does Reality Look Like? Findings from Germany and Other European Countries
Ulrich Keil, University of Munster, Munster, Germany
What is an Optimal Diet?
Dean Ornish, Preventive Medicine Research Institute, Sausalito, CA, U.S.A.
DILATED CARDIOMYOPATHY: VARIOUS ETIOLOGIES
Advances in the Diagnosis and Treatment  of Inflamatory Cardiomyopathy
Heinz-Peter Schultheiss, University Hospital Benjamin Franklin, Berlin, Germany
Cytokines in Adriamycin Induced Heart Failure
Pawan K. Singal, University of Manitoba, Winnipeg, Manitoba, Canada
Ventricular Remodeling Post-Infarction and Collagen
Bodh I. Jugdutt, University of Alberta Hospitals, Edmonton, Alberta, Canada
Virus Myocarditis as a Predictor of Dilated Cardiomyopathy, Possibilities for the Prevention of DCM
Nodar N. Kipshidze, Institute of Experimental and Clinical Therapy, Tbilisi, Rep. of Georgia
Myocardial Flow-Metabolism Abnormalities in Dilated Cardiomyopathy: Cause or Effect of Ventricular Dysfunction?
Danilo Neglia, CNR Institute of Clinical Physiology, Pisa, Italy
Arrhymogenic Right Ventricular Dysplasia/Cardiomyopathy - Diagnosis and Treatment
Charles Y. Lui, University of Arizona Health Sciences Center, Tucson, AZ, U.S.A.
Chagas' Disease: What All Physicians Need to Know
Anis Rassi Jr., Goiania, Brazil
NATRIURETIC PEPTIDES, ENDOTHELIN IN HEART FAILURE
The Appropriate Use of BNP as a Diagnostic Tool in Heart Disease
Richard J. Rodeheffer, Mayo Clinic, Rochester, MN, U.S.A.
Systemic and Coronary Hemodynamic Effects of B-Type Natriuretic Peptide Nesiritide
Kanu Chatterjee, University Of California San Francisco, CA, U.S.A.
Differential Secretion Patterns of Natriuretic Peptides in a Heart Failure Population and Their Association with Cardiac Function
Denise M. Heublein, Cardiorenal Research Laboratory, Mayo Clinic, Rochester, MN, U.S.A.
BNP in Acute Heart Failure
Andrew Burger, Beth Israel Deaconess Medical Center, Boston, MA, U.S.A.
Endothelin Antagonists in Cardiovascular Disease: New Preclinical and Clinical Data
Rene R. Wenzel, University Hospital Essen, Essen, Germany
Natriuretic Peptides in Asymptomatic and Symptomatic Severe Aortic Stenosis
Jutta Bergler-Klein, University of Vienna, Vienna, Austria
PREDICTORS AND MARKERS OF HEART FAILURE OUTCOME
Heart Rate Variability in Systolic and Diastolic Heart Failure of the Elderly
John S. Gottdiener, St. Francis Hospital, Roslyn, NY, U.S.A.
Implantable Physiologic Optimized Dosimeter/Synchonizer for Treating Advanced Congestive Heart Failure
Neal Eigler, Cedars-Sinai Medical Center, Los Angeles, CA  90048, U.S.A.
LEFT VENTRICULAR HYPERTROPHY AND HYPERTROPHIC CARDIOMYOPATHY
Catheter Based Treatment for HOCM: Studies on Myocardial Infarction in a Unique Clinical Infarct Model
Horst Kuhn, Bielefeld, Germany
Non-sarcomeric Causes of Familial Hypertrophic Cardiomyopathy
Lameh  Fananapazir, National Heart, Lung and Blood Institute, Bethesda, MD, U.S.A.
DIASTOLIC DYSFUNCTION
The Clinical Characteristics, Co-morbid Conditions and Natural History of Patients Hospitalized for Heart Failure with a Normal Left Ventricular Ejection Fraction
Marc Klapholz, Saint Vincent Catholic Medical Center, New York, NY, U.S.A.
ROLE OF THE PERICARDIUM
Pericardial Involvement in End-Stage Renal Disease
Martin A. Alpert, St. John's Mercy Medical Center, St. Louis, MO, U.S.A.
HEART FAILURE IN WOMEN
Psychosocial and Hormonal Contributors to the Development and the Progression of Heart Failure in Females
Vera Regitz-Zagrosek, German Heart Institute, Berlin, Germany
EXERCISE PHYSIOLOGY IN HEART FAILURE
Exercise Training in Patients with Chronic Heart Failure: Why, When, and How Much?
Gunter Gorge, Klinikum Saarbruecken, Saarbrucken, Germany
RENAL ASPECTS
The Changing Role of Ultrafiltration for Management of Decompensated Heart Failure - Not Just for the Nephrologist Anymore
Mitchell Saltzberg, Midwest Heart Specialists, Downers Grove, IL, U.S.A.
NEW HORIZONS IN THE MANAGEMENT OF HEART FAILURE
BNP: New Strategies for the Treatment of Cardiovascular Disease
John C. Burnett, Mayo Clinic and Foundation, Rochester, MN, U.S.A.
Hospitalization for Heart Failure: Pathophysiology and Management
Mihai Gheorghiade, Northwestern University, Chicago, IL, U.S.A.
Decompensated Heart Failure - Vasodilators or Inotropes
Uri Elkayam, USC School of Medicine, Los Angeles, CA, U.S.A.
New Approaches to the Treatment of Heart Failure
Robert C. Bourge, The University of Alabama, Birmingham, Birmingham, AL, U.S.A.
New Therapies for Heart Failure
Robert E. Hobbs, The Cleveland Clinic Foundation, Cleveland, OH, U.S.A.
Is Palliative Care Useful for Patients With Severe Heart Failure?
Herbert J. Geschwind, University of Paris XII, Val-de-Marne, Creteil, France
The Management of Heart Disease in 2003: Pearls and Pitfalls
Maryl R. Johnson, University of Wisconsin-Madison, Madison, WI, U.S.A.
Digoxin Pharmacotherapy in Patients with Chronic Cor Pulmonale. In Fact, Is It a Dilemma?
Nestor J. Angomachalelis, Aristotle University, School of Medicine, Thessaloniki, Macedonia, Greece
Targeting Phospholamban as a Therapeutic Modality in Heart Failure
Litsa Kranias, University of Cincinnati Medical Center, Cincinnati, OH, U.S.A.
CARDIAC PACING STRATEGIES IN HEART FAILURE
Electrical Therapy for Congestive Heart Failure
Masood Akhtar, Sinai Samaritan Medical Center, Milwaukee, WI, U.S.A.
Electrophysiological Interventions in Management of Cardiac Failure
Gerard Marcel Guiraudon, University Hospital, London, Ontario, Canada
Heart Failure and the Need for Device Therapy
William Abraham, The Ohio State University, Columbus, Ohio, U.S.A.
CARDIOPULMONARY RESUSCITATION
Why Are the Guidelines for Basic CPR Wrong?
Gordon A. Ewy, University of Arizona Sarver Heart Center, Tucson, AZ, U.S.A.
Novel Steps in the Journey Toward Optimizing Care for the Victim of Sudden Cardiac Arrest
Alessandro Capucci, Ospedale Civile, Piacenza, Italy
Advances in Cardiopulmonary Resuscitation
Gerasimos S. Filippatos, Athens, Greece
ARRHYTHMIAS I: SUDDEN CARDIAC DEATH / RISK STRATIFICATION / IMPLANTABLE ANTIARRHYTHMIC DEVICES
Risk Identification in Arrhythmic Athletes with Fatal or Resuscitated Cardiac Arrest
Francesco Furlanello, Policlinico San Donato Milanese - Milan, Povo (TN), Italy
Sudden Cardiac Death Prevention in High Risk Familial Syndrome
Win-Kuang Shen, Mayo Clinic, Rochester, MN, U.S.A.
Do All Patients With Coronary Artery Disease and an Ejection Fraction of Less Than 30% Need a Defibrillator?
Douglas L. Packer, St. Mary's Hospital Complex, Rochester, MN, U.S.A.
Sudden Cardiac Death: The Clinical and Public Health Challenges
George Mensah, Center for Disease Control and Prevention, Atlanta, GA, U.S.A. 
New Alternatives for Patients Suffering In-Hospital Cardiac Arrest: the Role of Fully Automatic Defibrillators
Antonio Martinez-Rubio,
Hospital of Sabadell, Barcelona, Spain
Post-infarction Signaling Pathways as Targets for Novel Therapeutic Interventions
Nabil E. El-Sherif, SUNY Downstate Medical Center, Brooklyn, NY, U.S.A.
Primary Prevention of Sudden Death: Current Role of Implantable Device Therapy
David J. Wilber, Loyola University Medical Center, Maywood, IL, U.S.A.
Frontiers in Complete Congenital Heart Block
Mohamed Boutjdir, NY Harbor Healthcare System, Brooklyn, NY, U.S.A.
ARRHYTHMIAS II: DIAGNOSIS / DRUG THERAPY / ABLATION
Interatrial Block: Electromechanical Disease of the Left Atrium - A Very Common Condition
David H. Spodick, University of Massachusetts Medical School, Worcester, MA, U.S.A.
Atrial Flutter Mechanisms: New Concepts of Interest for the Clinician
Jose L. Merino, Hospital General Universitarion "La Paz", Madrid, Spain
Recent Advances in the Non-Pharmacologic Treatment of Atrial Fibrillation
Peter G. Guerra, Montreal Heart Institute, Montreal, Quebec, Canada
VALVULAR HEART DISEASE / HEART VALVE SURGERY / DISEASES OF THE THORACIC AORTA
Confirmation of Contractility as a Prognostic Index in Aortic Regurgitation, and the Cellular/Molecular Basis of the Deficit
Jeffrey S. Borer, The New York Hospital, Cornell Medical Center, New York, NY, U.S.A.
Etiology of Valvular Heart Disease in the 21st Century
Harisios Boudoulas, Academy of Athens, Athens, Greece
Transcatheter Treatment of Mitral Regurgitation
Peter C. Block, Emory University Hospital, Atlanta, GA, U.S.A.
Mechanical Properties of the Aorta in Normal and Aneurysmal States
John A. Elefteriades, Yale University School of Medicine, New Haven, CT, U.S.A.
Mitral and Tricuspid Reconstruction in the Patients with Heart Failure
Ninoslav Radovanovic, University Clinic of Cardiovascular Surgery, Sremska Kamenica, Novi Sad, Yugoslavia
Rational Behind the Biological Aortic Valve Replacement
Borut Gersak, University Medical Center, Ljubljana, Slovenia
Robotic Mitral Valve Repair: Improved Results and Patient Satisfaction
Mark S. Slaughter, Christ Hospital and Medical Center, Oak Lawn, IL, U.S.A.
NEW APPROACHES TO SURGICAL REVASCULARIZATION
Totally Endoscopic CABG
Daniel Loisance, Hopital Henri Mondor, Cretail Cedex, France
Purely Internal Mammary Artery CABG for Complete Myocardial Revascularization
Patrick Nataf, Center Cardiologique du Nord, saint Denis, France
Facilitative Techniques to Advance Minimally Invasive Concept of Coronary Artery Bypass Surgery and Surgical Treatment for Heart Failure
Valavanur A. Subramanian, Lenox Hill Hospital, New York, NY U.S.A.
Assessment of Myocardial Viability in Heart Failure: Who Should Be Revascularized?
Vasken Dilsizian, University of Maryland School of Medicine, Baltimore, MD, U.S.A.
Recent Advances in Cardiac Surgery
Mercedes K. C. Dullum, Washington Regional Cardiac Surgery PC, Washington DC, U.S.A.
SURGERY FOR LV DYSFUNCTION, CARDIAC TRANSPLANTATION, MECHANICAL SUPPORT
Fetal Intervention to Prevent Hypoplastic Left Heart Syndrome
Steven Colan, Children's Hospital Boston, Boston, MA, U.S.A.
Heart Transplantation with Bicaval and Pulmonary Venous Anastomoses
Lawrence S. Czer, Cedars-Sinai Medical Center, Los Angeles, CA, U.S.A.
Surgical Trials for the Management of Heart Failure
Dan M. Meyer, University of Texas Southwestern Medical Center, Dallas, TX, U.S.A.
Management of Pulmonary Hypertension in Cardiac Transplant Recipients
Geetha Bhat, University of Louisville and Jewish Hospital, Louisville, KY, U.S.A.
Mechanical Circulatory Support in Infants and Children with Cardiac Disease
Brian W. Duncan, The Children's Hospital at the Cleveland Clinic, Cleveland, OH, U.S.A.
New Agents and New Strategies in Immunosuppression After Heart Transplantation
Bruno M. Meiser, University of Munich, Klinikum Grosshadern, Munich, Germany
Non-Transplant Surgery for Heart Failure
Jai Raman, The University of Chicago Medical Center, Chicago, Illinois, U.S.A.
First Results with Rapamycin Replacing Cyclosporin After Heart Transplantation, Is There an Advantage Concerning Graftsklerosis?
Suzanne Roedler, University of Vienna, Vienna, Austria